Growth Metrics

Myomo (MYO) Operating Leases (2020 - 2025)

Myomo posted quarterly Operating Leases of $7.7 million for Q4 2025, up 4.18% year-on-year from $7.4 million in Q4 2024, and down 2.13% on a QoQ basis from $7.8 million in Q3 2025.

Myomo (MYO) has 6 years of Operating Leases data on file, last reported at $7.7 million in Q4 2025.

  • For the quarter ending Q4 2025, Operating Leases rose 4.18% year-over-year to $7.7 million; the trailing twelve-month figure through Dec 2025 stood at $7.7 million (up 4.18% YoY), and the FY2025 full-year result was $7.7 million, up 4.18% from the prior year.
  • Operating Leases for Q4 2025 stood at $7.7 million, down from $7.8 million in the prior quarter.
  • Across five years, Operating Leases topped out at $8.0 million in Q2 2025 and bottomed at $29165.0 in Q3 2024.
  • The 5-year median for Operating Leases is $365175.5 (2021), against an average of $2.1 million.
  • The widest annual swing landed in 2024, when Operating Leases sank 88.48%; it then surged 26756.58% in 2025.
  • A 5-year view of Operating Leases shows it stood at $401622.0 in 2021, then sank by 50.15% to $200207.0 in 2022, then sank by 42.48% to $115160.0 in 2023, then soared by 6289.53% to $7.4 million in 2024, then gained by 4.18% to $7.7 million in 2025.
  • The last three Operating Leases figures came in at $7.7 million (Q4 2025), $7.8 million (Q3 2025), and $8.0 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Myomo 44.63 Mn 26.23 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 7.67 Mn
Sep 30, 2025 7.83 Mn
Jun 30, 2025 7.97 Mn
Mar 31, 2025 7.50 Mn
Dec 31, 2024 7.36 Mn
Sep 30, 2024 29,165.00
Jun 30, 2024 47,338.00
Mar 31, 2024 64,599.00
Dec 31, 2023 115,160.00
Sep 30, 2023 253,210.00
Jun 30, 2023 139,657.00
Mar 31, 2023 169,770.00
Dec 31, 2022 200,207.00
Sep 30, 2022 220,901.00
Jun 30, 2022 328,729.00
Mar 31, 2022 453,073.00
Dec 31, 2021 401,622.00
Sep 30, 2021 474,188.00
Jun 30, 2021 562,887.00
Mar 31, 2021 644,107.00
Dec 31, 2020 155,148.00